Navigation Links
U of M researcher examines newly emerging deadly disease

Researchers at the University of Minnesota have identified a newly emerging illness, named staphylococcal purpura fulminans. The disease begins as a respiratory tract infection, which then is infected by Staphylococcus aureus. The infection then moves to the lungs, making superantigens (bacterial toxins that activate large numbers of T cells), often leading to death due to hypertension and shock. Purpura fulminans has been identified in five cases in the Minneapolis-St. Paul, Minn., metropolitan area during 2000-2004, as described in the April 1, 2005 issue of Clinical Infectious Diseases. This new disease has also been determined in seven additional cases nationwide. Of the 12 known cases, only two patients have survived.

Purpura fulminans is an acute illness commonly associated with meningococcemia or invasive streptococcal disease, and it is typically characterized by the depletion of clotting factors in the blood and skin lesions. Purpura fulminans refers to widespread severe purpura with extensive tissue damage and sloughing of skin. Purpura are skin lesions that may be many centimeters in diameter caused by the leakage of blood into the skin.

"It is important to alert medical professionals about the symptoms and treatments of this new deadly disease," said Patrick Schlievert, Ph.D., professor of microbiology at the University of Minnesota Medical School. "We are continuing to study and monitor cases of purpura fulminans to better understand the causes and best treatment options."

On the basis of experience, the University of Minnesota experts have identified three recommended treatments for purpura fulminans. Patients who present symptoms of purpura should receive antibiotic therapy not only against Neisseria meningitidis and streptococci, but also against methicillin-resistant S. aureus (MRSA), with the consideration that the staphylococcal disease may be more common than the two prior illnesses. Patients should also be given early admi
'"/>

Source:University of Minnesota


Page: 1 2

Related biology news :

1. NYU researchers simulate molecular biological clock
2. Vital step in cellular migration described by UCSD medical researchers
3. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
4. UCSD researchers maintain stem cells without contaminated animal feeder layers
5. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
6. New protein discovered by Hebrew University researchers
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Agilent Technologies releases automated literature search tool for biology researchers
9. Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin
10. Yale researchers identify molecule for detecting parasitic infection in humans
11. US life expectancy about to decline, researchers say

Post Your Comments:
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
(Date:11/4/2009)... LEADS: (top news in natural science) , Unit...tates uses less water today than it did 35 years a...ines in water use are partly attributable to alter...ficient irrigation systems. According to the lates...used in the United States goes to cooling thermoel...
(Date:11/4/2009)...The Singapore laboratory that deciphered the DNA c...) and elephant shark, has joined The Genome 10K Pr...ble repository of DNA sequences on 10,000 species ... scale that currently can not be achieved. , Par... a paper published in the Nov. 5, 2009 issue of th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 1American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 2Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 1Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 2Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 1Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 2
...g to the growing popularity of a plant-based sweet...y announced it is developing a new standard to be ...ll help food and beverage manufacturers assure the...omments from the food and beverage industry as wel...new standard for this new sweetener, Rebaudioside ...
...g? , A new study suggests that while health care ...conomy, achieving a substantial, sustainable reduc...he author, who completed health care policy litera...spite far greater expenditures, US hospitalization...ds are all lower than they are in other first-worl...
...atments is the difficulty of aiming these treatmen...ealthy cells in the process. But a new study by Mc... into how scientists might develop therapies and d...ing normal healthy cells , Mick Bhatia, scientifi...search Institute in the Michael G. DeGroote School...
Other Biology News:New standard for popular stevia-based sweetener to assure product's quality 2Plastic and reconstructive surgery -- in brief 2Plastic and reconstructive surgery -- in brief 3Scientists can now differentiate between healthy cells and cancer cells 2
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...ay 29 The Gerresheimer,Group today opened a new p...The high-tech production facility constructed in D...ers. Specializing in high-quality pharmaceutical,v...s the pharma & life,science industry on both a...EO of Gerresheimer AG, describes the investment as...
...RNewswire-FirstCall/ - YM BioSciences Inc. (NYSE A... that identifies, develops and commercializes diff...announced that a poster presentation will report r... BIOMAb/TheraCIM/h-R3) in patients with head and n... India), a licensee of CIMAB SA, YM,s licensor, at...
...0th patient was supported with the,Berlin Heart EX...nown as the,"Berlin Heart") since the first implan...onth-old girl, received the device at the Children...ssfully transplanted in the meantime. , Alejan...h left,ventricular non compaction and dilative car...
Other Biology Technology:Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 2Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 3YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 3500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: